22.05 (-%)
As of Nov 22, 2024
Source:
We are a clinical-stage biotechnology companydedicated to enabling cures through hematopoietic stem cell therapy. We are focused on the development and commercialization of saferand more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo genetherapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.
Country | United States |
Headquarters | redwood city, california |
Phone Number | 6505491400 |
Industry | finance |
CEO | Ronald Martell |
Website | www.jaspertherapeutics.com |